SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM

被引:0
|
作者
Neri, B. [1 ]
D'Agostini, G. [1 ]
Salvatori, S. [1 ]
Mossa, M. [1 ]
Bettin, F. [1 ]
Marafini, I [1 ]
Lolli, E. [1 ]
Calabrese, E. [1 ]
Monteleone, G. [1 ]
Biancone, L. [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Syst Med, Gastroenterol Unit, Rome, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OC.14.1
引用
收藏
页码:S124 / S124
页数:1
相关论文
共 50 条
  • [1] Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term
    Neri, Benedetto
    D'Agostini, Giorgia
    Salvatori, Silvia
    Mossa, Michelangela
    Bettin, Federica
    Mancone, Roberto
    Marafini, Irene
    Lolli, Elisabetta
    Calabrese, Emma
    Monteleone, Giovanni
    Biancone, Livia
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (09) : 948 - 954
  • [2] SARS-CoV-2 infection does not seem to worsen the clinical course of patients with oral autoimmune disease
    Arduino, Paolo G.
    Gambino, Alessio
    Broccoletti, Roberto
    [J]. ORAL DISEASES, 2022, 28 : 2593 - 2594
  • [3] Incidence of SARS-CoV-2 infection in inflammatory bowel disease
    Lee, M. H.
    Ng, C. H.
    Chin, Y. H.
    Muthiah, M.
    Foo, F. J.
    Chong, C. S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 2021 - 2022
  • [4] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    K. A. Dvornikova
    E. Yu. Bystrova
    L. P. Churilov
    A. Lerner
    [J]. Molecular Biology Reports, 2021, 48 : 5745 - 5758
  • [5] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    Dvornikova, K. A.
    Bystrova, E. Yu.
    Churilov, L. P.
    Lerner, A.
    [J]. MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5745 - 5758
  • [6] Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease
    Scucchi, L.
    Neri, B.
    Sarmati, L.
    Mossa, M.
    Sena, G.
    Massoud, R.
    Petruzziello, C.
    Musumeci, M.
    Marafini, I
    Calabrese, E.
    Lolli, E.
    Bernardini, S.
    Andreoni, M.
    Monteleone, G.
    Biancone, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2418 - 2424
  • [7] DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY?
    De Blasio, F.
    Montori, M.
    Martini, F.
    Paolucci, L.
    Vitalini, T.
    Pieroni, G.
    Quatraccioni, C.
    Benedetti, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 : S138 - S138
  • [8] Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease
    Teich, Niels
    Ludewig, Clara
    Schmelz, Renate
    Baestlein, Elke Christiane
    Geissler, Sven
    Nagl, Sandra
    Walldorf, Jens
    Krause, Thomas
    Maaser, Christian
    Mohl, Wolfgang
    Wedemeyer, Heiner H.
    Bauer, Tilman
    Buening, Carsten
    Grunert, Philip
    Hasselblatt, Peter
    Haenschen, Markus
    Kahl, Matthias
    Engelke, Olaf
    Schubert, Stefan
    Holler, Babett
    Streetz, Konrad
    von Arnim, Ulrike
    Schmidt, Karen
    Stallmach, Andreas
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (11): : 1189 - 1196
  • [9] SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
    Ruan, Wenly
    Ihekweazu, Faith
    Walsh, Seema
    Karam, Lina
    Wyatt, Allyson
    Huyen Nguyen
    Kellermayer, Richard
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 : S44 - S45
  • [10] SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
    Ruan, Wenly
    Ihekweazu, Faith
    Walsh, Seema
    Karam, Lina
    Wyatt, Allyson
    Nguyen, Huyen
    Kellermayer, Richard
    [J]. GASTROENTEROLOGY, 2021, 160 (03) : S60 - S61